1. Home
  2. Medications
  3. Heart & Blood Pressure
PetMeds Reviews
Prescription Item Prescription Item Prescription Item
1. We'll ask for your vet's info during checkout.
2. We verify your prescription and ship your order!
Vetmedin-CA1 1.25mg, 50ct product detail number 1.0 Watch the latest from Petmeds Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct

Vetmedin-CA1

Vetmedin
4.8 out of 5 Customer Rating
Star symbol Star symbol Star symbol Star symbol Star symbol (0)
|
0 Questions Answered
$55.69
save big
Prescription Item Prescription Item Prescription Item
1. We'll ask for your vet's info during checkout.
2. We verify your prescription and ship your order!
Vetmedin-CA1 1.25mg, 50ct product detail number 1.0 Watch the latest from Petmeds Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct Vetmedin-CA1 1.25mg, 50ct
rx disclaimer Additional Information About Your Prescription
$55.69
Quantity:
Please select all product options.
$52.91
(5% off every order)
35% off your first order

Use code SAVE35 in cart

Up to $20 off, exclusions apply
  • Guaranteed savings on every order
  • Pause, skip or cancel anytime
  • Free access to licensed vets
Ship every:
Checkbox Out of stock
Estimated back in stock soon. Be the first to know.
Quantity:
Please select all product options.
Price Match Guarantee
Price Matching
Easy Returns
Free & Easy Returns

What is Vetmedin-CA1?

VETMEDIN®-CA1 (pimobendan) chewable tablets is conditionally approved for the treatment of dogs with myxomatous mitral valve disease (MMVD) in the pre-clinical stage B2 (asymptomatic with a murmur/abnormal heart sounds and evidence of increased heart size) to delay onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-556 (please see full prescribing information).

Given every 12 hours, the unique dual action of VETMEDIN®-CA1 dilates the blood vessels carrying blood to and from the heart—reducing the overall load on the heart—while simultaneously improving the ability of the heart muscle to contract.

The active ingredient in VETMEDIN®-CA1 (pimobendan) helps the heart muscle to contract and relax (pump) more effectively and it dilates blood vessels which reduces the amount of force with which the heart needs to pump blood.

Suitable for:

Dogs

Benefits:

  • Recommended for dogs diagnosed with Stage B2 MMVD, VETMEDIN®-CA1 (pimobendan) can be used for the delay of onset of congestive heart failure.
  • May prolong the number of symptom-free days in dogs.
  • VETMEDIN®-CA1 helps dogs continue to engage in the daily activities they enjoy.
  • Available as a beef-flavored, chewable tablet in 2 convenient dosing sizes (1.25 mg and 5 mg).

How does Vetmedin-CA1 work?

VETMEDIN-CA1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease (2019 ACVIM Consensus Statement1 ).

Caution:

Observe good industrial hygiene practices. Wash hands after handling.

Storage:

Keep out of reach of children and pets. Store at 20 to 25°C (68° to 77°F). Store away from incompatible materials. Dispose of waste and residues in accordance with local authority requirements.

Brand Name:

VETMEDIN®-CA1

Generic Name:

pimobendan

What is the most important thing I should know about Vetmedin-CA1?

For dogs with valvular insufficiency it extends life and improves quality of life.

What should I discuss with my veterinarian before giving Vetmedin-CA1 to my pet?

If there is a prescription for Vetmedin CA-1, there should be no questions. If there is no prescription, they should ask if their dog is a candidate for Vetmedin CA-1. VETMEDIN®-CA1 should be given to your dog once a veterinarian has confirmed that it meets the criteria for Stage B2 preclinical myxomatous mitral valve disease.

How should Vetmedin-CA1 be given ?

Give by mouth as prescribed.

What are the potential side effects of Vetmedin-CA1?

The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough, vomiting, diarrhea, lethargy (lack of energy), and localized pain (such as in the neck or legs). If side effects occur, consult your veterinarian. 

What happens if I miss giving a dose of Vetmedin-CA1?

If a dose of VETMEDIN®-CA1 is missed give the next scheduled dose at the normal time. There’s no need to give a higher dose.

What happens if I overdose my pet on Vetmedin-CA1?

Call your veterinarian.

What should I avoid while giving Vetmedin-CA1 to my pet?

Avoid leaving the bottle where the dog can access it. There are reported cases where dogs get into the bottle and eat all the tablets.

What other drugs will affect Vetmedin-CA1?

There are no known adverse drug interactions

Vetmedin-CA1 Directions:

  • VETMEDIN-CA1 should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight, using a suitable combination of whole or half tablets.
  • The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (i.e., morning and evening).
Tip:

The tablets are scored, and the calculated dosage should be provided to the nearest half tablet increment

Vetmedin-CA1 Dosage:

Vetmedin-CA1 Dosage for Dogs
Weight Dosage
All weights .23mg per 1lb body weight
Vetmedin-CA1 Dosage for Cats:
Cats
Do not use!
Vetmedin-CA1 Dosage for Horses:
Horses
Do not use!

Vetmedin-CA1 Ingredients:

Vetmedin-CA1
Active Ingredients: pimobendan

Vetmedin-CA1 FAQs:

  • How can VETMEDIN®-CA1 (pimobendan) help my dog?

    • VETMEDIN®-CA1 is conditionally approved to delay the onset of clinical signs of heart failure in dogs diagnosed with myxomatous mitral valve disease and evidence of an enlarged heart (known as Stage B2 heart disease).

  • How do VETMEDIN®-CA1 (pimobendan) Chewable Tablets work?

    • VETMEDIN®-CA1 has a unique dual mode of action, dilating the blood vessels carrying blood to and from the dog’s heart, reducing the load on the heart. It also increases the contraction of the heart muscle, without putting additional stress on the heart.

  • What is a conditional approval for animal drugs?

    • The FDA-CVM grants conditional approval for animal drugs to treat serious, life-threatening diseases for which there are no approved therapies available. Drug safety has been demonstrated and the drug is manufactured in accordance with full approval standards. The drug has reasonable expectations of effectiveness, but full effectiveness data is still being collected.

  • At what dose and how often should I give VETMEDIN®-CA1 (pimobendan) to my dog?

    • VETMEDIN®-CA1 should be administered per your veterinarian’s prescription specific to your dog.

  • How do I give VETMEDIN®-CA1 (pimobendan) to my dog?

    • VETMEDIN®-CA1 should be given to your dog in their mouth (orally) twice a day, about 12 hours apart. The tablets are scored so that a combination of whole or half tablets may be given to your dog. Because of differences in tablet sizes and dog sizes, the dose you are prescribed to give your dog in the morning may be the same or different from the evening dose. Please give VETMEDIN®-CA1 as directed by your veterinarian.

  • When should I give my dog VETMEDIN®-CA1(pimobendan)?

    • VETMEDIN®-CA1 should be given to your dog once a veterinarian has confirmed that it meets the criteria for Stage B2 preclinical myxomatous mitral valve disease.

  • What should I do if I miss a dose of VETMEDIN®-CA1 (pimobendan)?

    • If a dose of VETMEDIN®-CA1 is missed give the next scheduled dose at the normal time. There’s no need to give a higher dose.

  • What dosing options does VETMEDIN®-CA1 (pimobendan) come in?

    • VETMEDIN®-CA1 (pimobendan) is available as a beef-flavored, chewable tablet in 2 convenient dosing sizes (1.25 mg and 5 mg).

  • Can VETMEDIN®-CA1 (pimobendan) be used with all dogs?

    • VETMEDIN®-CA1 is conditionally approved for the delay of onset of clinical signs of heart failure in dogs with B2, pre-clinical (asymptomatic with murmur/abnormal heart sounds and evidence of increased heart size) myxomatous mitral valve disease. The safe use of VETMEDIN®-CA1 has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating dogs.

  • What are the side effects of VETMEDIN®-CA1 (pimobendan)?

    • The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough, vomiting, diarrhea, lethargy (lack of energy), and localized pain (such as in the neck or legs). If side effects occur, consult your veterinarian. 

  • What is the best number to call regarding any specific product questions?

    • For any specific product questions, please call Boehringer Ingelheim Animal Health’s customer service line number at 1-888-637-4251.

What is Vetmedin-CA1?

VETMEDIN®-CA1 (pimobendan) chewable tablets is conditionally approved for the treatment of dogs with myxomatous mitral valve disease (MMVD) in the pre-clinical stage B2 (asymptomatic with a murmur/abnormal heart sounds and evidence of increased heart size) to delay onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-556 (please see full prescribing information).

Given every 12 hours, the unique dual action of VETMEDIN®-CA1 dilates the blood vessels carrying blood to and from the heart—reducing the overall load on the heart—while simultaneously improving the ability of the heart muscle to contract.

The active ingredient in VETMEDIN®-CA1 (pimobendan) helps the heart muscle to contract and relax (pump) more effectively and it dilates blood vessels which reduces the amount of force with which the heart needs to pump blood.

Suitable for:

Dogs

Benefits:

  • Recommended for dogs diagnosed with Stage B2 MMVD, VETMEDIN®-CA1 (pimobendan) can be used for the delay of onset of congestive heart failure.
  • May prolong the number of symptom-free days in dogs.
  • VETMEDIN®-CA1 helps dogs continue to engage in the daily activities they enjoy.
  • Available as a beef-flavored, chewable tablet in 2 convenient dosing sizes (1.25 mg and 5 mg).

How does Vetmedin-CA1 work?

VETMEDIN-CA1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease (2019 ACVIM Consensus Statement1 ).

Caution:

Observe good industrial hygiene practices. Wash hands after handling.

Storage:

Keep out of reach of children and pets. Store at 20 to 25°C (68° to 77°F). Store away from incompatible materials. Dispose of waste and residues in accordance with local authority requirements.

Brand Name:

VETMEDIN®-CA1

Generic Name:

pimobendan

What is the most important thing I should know about Vetmedin-CA1?

For dogs with valvular insufficiency it extends life and improves quality of life.

What should I discuss with my veterinarian before giving Vetmedin-CA1 to my pet?

If there is a prescription for Vetmedin CA-1, there should be no questions. If there is no prescription, they should ask if their dog is a candidate for Vetmedin CA-1. VETMEDIN®-CA1 should be given to your dog once a veterinarian has confirmed that it meets the criteria for Stage B2 preclinical myxomatous mitral valve disease.

How should Vetmedin-CA1 be given ?

Give by mouth as prescribed.

What are the potential side effects of Vetmedin-CA1?

The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough, vomiting, diarrhea, lethargy (lack of energy), and localized pain (such as in the neck or legs). If side effects occur, consult your veterinarian. 

What happens if I miss giving a dose of Vetmedin-CA1?

If a dose of VETMEDIN®-CA1 is missed give the next scheduled dose at the normal time. There’s no need to give a higher dose.

What happens if I overdose my pet on Vetmedin-CA1?

Call your veterinarian.

What should I avoid while giving Vetmedin-CA1 to my pet?

Avoid leaving the bottle where the dog can access it. There are reported cases where dogs get into the bottle and eat all the tablets.

What other drugs will affect Vetmedin-CA1?

There are no known adverse drug interactions

Vetmedin-CA1 Directions:

  • VETMEDIN-CA1 should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight, using a suitable combination of whole or half tablets.
  • The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (i.e., morning and evening).
Tip:

The tablets are scored, and the calculated dosage should be provided to the nearest half tablet increment

Vetmedin-CA1 Dosage:

Vetmedin-CA1 Dosage for Dogs
Weight Dosage
All weights .23mg per 1lb body weight
Vetmedin-CA1 Dosage for Cats:
Cats
Do not use!
Vetmedin-CA1 Dosage for Horses:
Horses
Do not use!

Vetmedin-CA1 Ingredients:

Vetmedin-CA1
Active Ingredients: pimobendan

Vetmedin-CA1 FAQs:

  • How can VETMEDIN®-CA1 (pimobendan) help my dog?

    • VETMEDIN®-CA1 is conditionally approved to delay the onset of clinical signs of heart failure in dogs diagnosed with myxomatous mitral valve disease and evidence of an enlarged heart (known as Stage B2 heart disease).

  • How do VETMEDIN®-CA1 (pimobendan) Chewable Tablets work?

    • VETMEDIN®-CA1 has a unique dual mode of action, dilating the blood vessels carrying blood to and from the dog’s heart, reducing the load on the heart. It also increases the contraction of the heart muscle, without putting additional stress on the heart.

  • What is a conditional approval for animal drugs?

    • The FDA-CVM grants conditional approval for animal drugs to treat serious, life-threatening diseases for which there are no approved therapies available. Drug safety has been demonstrated and the drug is manufactured in accordance with full approval standards. The drug has reasonable expectations of effectiveness, but full effectiveness data is still being collected.

  • At what dose and how often should I give VETMEDIN®-CA1 (pimobendan) to my dog?

    • VETMEDIN®-CA1 should be administered per your veterinarian’s prescription specific to your dog.

  • How do I give VETMEDIN®-CA1 (pimobendan) to my dog?

    • VETMEDIN®-CA1 should be given to your dog in their mouth (orally) twice a day, about 12 hours apart. The tablets are scored so that a combination of whole or half tablets may be given to your dog. Because of differences in tablet sizes and dog sizes, the dose you are prescribed to give your dog in the morning may be the same or different from the evening dose. Please give VETMEDIN®-CA1 as directed by your veterinarian.

  • When should I give my dog VETMEDIN®-CA1(pimobendan)?

    • VETMEDIN®-CA1 should be given to your dog once a veterinarian has confirmed that it meets the criteria for Stage B2 preclinical myxomatous mitral valve disease.

  • What should I do if I miss a dose of VETMEDIN®-CA1 (pimobendan)?

    • If a dose of VETMEDIN®-CA1 is missed give the next scheduled dose at the normal time. There’s no need to give a higher dose.

  • What dosing options does VETMEDIN®-CA1 (pimobendan) come in?

    • VETMEDIN®-CA1 (pimobendan) is available as a beef-flavored, chewable tablet in 2 convenient dosing sizes (1.25 mg and 5 mg).

  • Can VETMEDIN®-CA1 (pimobendan) be used with all dogs?

    • VETMEDIN®-CA1 is conditionally approved for the delay of onset of clinical signs of heart failure in dogs with B2, pre-clinical (asymptomatic with murmur/abnormal heart sounds and evidence of increased heart size) myxomatous mitral valve disease. The safe use of VETMEDIN®-CA1 has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating dogs.

  • What are the side effects of VETMEDIN®-CA1 (pimobendan)?

    • The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough, vomiting, diarrhea, lethargy (lack of energy), and localized pain (such as in the neck or legs). If side effects occur, consult your veterinarian. 

  • What is the best number to call regarding any specific product questions?

    • For any specific product questions, please call Boehringer Ingelheim Animal Health’s customer service line number at 1-888-637-4251.

Other Options
Swipe

Customers who bought also boughtView All

Swipe